Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01433172
What this trial is testing

Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer

Who this might be right for
Lung CancerAdenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute 73
Early research (Phase 1)Study completedNCT02219711
What this trial is testing

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Mirati Therapeutics Inc. 193
Testing effectiveness (Phase 2)Ended earlyNCT03207867
What this trial is testing

NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma

Who this might be right for
NSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more
Novartis Pharmaceuticals 315
Not applicableActive Not RecruitingNCT00499330
What this trial is testing

Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Ended earlyNCT05420636
What this trial is testing

Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

Who this might be right for
Small-cell Lung CancerNeuroendocrine Carcinoma
Fox Chase Cancer Center 20
Early research (Phase 1)Study completedNCT02120807
What this trial is testing

Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas

Who this might be right for
Stage IV Lung Adenocarcinoma
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT03126110
What this trial is testing

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 145
Not applicableStudy completedNCT02370303
What this trial is testing

Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System

Who this might be right for
Lung CancerLung NeoplasmsCancer of Lung+8 more
Mayo Clinic 23
Not applicableLooking for participantsNCT05838053
What this trial is testing

Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Who this might be right for
Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China 446
Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Not applicableStudy completedNCT01106781
What this trial is testing

A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 591
Large-scale testing (Phase 3)Study completedNCT00003901
What this trial is testing

Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 1,310
Testing effectiveness (Phase 2)Looking for participantsNCT07624487
What this trial is testing

Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma Metastatic
Taipei Medical University Hospital 50
Early research (Phase 1)Active Not RecruitingNCT06607185
What this trial is testing

The Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more
Eli Lilly and Company 750
Early research (Phase 1)Ended earlyNCT04025216
What this trial is testing

CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerOvarian CancerFallopian Tube Cancer+3 more
Kite, A Gilead Company 16
Large-scale testing (Phase 3)Study completedNCT00006484
What this trial is testing

Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network
Not applicableStudy completedNCT01236053
What this trial is testing

Cancer in Patients With Gabapentin (GPRD)

Who this might be right for
Pain, NeuropathicEpilepsyRenal Pelvis Cancer+13 more
GlaxoSmithKline 2,323,608
Not applicableUnknownNCT05907577
What this trial is testing

Early Detection of Lung Cancer With Machine Learning Based on Routine Clinical Investigations

Who this might be right for
Adenocarcinoma of Lung; Bronchial Neoplasms; Early Detection of Cancer; Machine Learning
The University Clinic of Pulmonary and Allergic Diseases Golnik 7,500
Early research (Phase 1)Ended earlyNCT04187872
What this trial is testing

LITT and Pembrolizumab in Recurrent Brain Metastasis

Who this might be right for
MelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more
University of Florida 10
Testing effectiveness (Phase 2)Study completedNCT02599194
What this trial is testing

18F-FSPG PET/CT for Cancer Patients on Therapy

Who this might be right for
B-Cell NeoplasmEstrogen Receptor NegativeHER2/Neu Negative+13 more
Andrei Iagaru 7
Next Page